We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

A shortage of intravenous and injectable saline solutions in the United States has now been resolved, U.S. Food and Drug ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

The stock's fall snapped a four-day winning streak.